Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
54results about How to "Safely ingested" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Safely ingestible batteries
ActiveUS9741975B2Avoid damageInhibitory contentCell seperators/membranes/diaphragms/spacersSmall-sized cells cases/jacketsQuantumElectron
Owner:MASSACHUSETTS INST OF TECH +1
Preparation method of igy for preventing and cure mouth disease and the toothpaste base on the igy
InactiveUS20060198849A1Prolong lifeHigh activityCosmetic preparationsEgg immunoglobulinsToothpasteMouth disorder
The present invention relates to a preparation method of IgY for preventing and cure mouth disease, and a safe toothpaste containing the IgY.
Owner:JASON MEDICAL GROUPFAR EASTLTD
Compositions and Methods for Oral Administration of Cannabinoids and Terpenoids
ActiveUS20190060225A1Precise and reliable dosageAct quicklyOrganic active ingredientsPowder deliveryDelivery vehicleCannabis Preparation
The present invention relates to oral administration of water soluble cannabinoid and terpenoid concentrates on a flavored fibrous carrier. The compositions described herein provide an alternative to smoked cannabis that also avoid the slow action and unpredictable dosing of edible cannabis preparations. Water soluble concentrates of cannabinoids and terpenoids may be produced by derivatization reactions which are known in the art. Such water soluble concentrates enjoy significantly increased absorption by mucosal membranes of the mouth and may therefore be experienced by the consumer more quickly. Water soluble cannabinoid and terpenoid concentrates may be used in combination with each other and in combination with non-derivatized molecules which provides the user with fast and slow acting components in a single delivery vehicle.
Owner:TRINIDAD CONSULTING LLC
Virucidal activities of cetylpyridinium chloride
This disclosure relates to inventive methods for inactivating viral pathogens in which the steps of the methods include: (a) providing a virucidal composition comprising a liquid media containing less than 1% weight per volume cetylpyridinium chloride; and (b) contacting the virucidal composition with a surface targeted for disinfection. This disclosure further relates to inventive virucidal compositions, in which the compositions include: (a) a liquid media; (b) cetylpyridinium chloride in solution in the liquid media at a concentration of less than 1% weight per volume; (c) an extender; and (d) an enhancer.
Owner:VIRATOX
Therapeutic supplement using ume fruit
InactiveUS20070243296A1Present inventionTreatment safetyDigestive systemFood shapingTherapeutic effectAdemetionine
A therapeutic supplement utilizes a processed form of the Ume fruit in the absence of the Ume seed. In a preferred form, the Ume fruit is processed to achieve a higher alkalinity to increase its therapeutic effectiveness.
Owner:BOURASSA ANUSCHKA M +1
Adiponectin secretion enhancer
ActiveUS20180228824A1Increase secretionSafely ingestedCosmetic preparationsDispersion deliveryFatty liverDietary supplement
The present disclosure provides for the administration of β-NMN, which increases the secretion of adiponectin. The present disclosure also provides an adiponectin secretion enhancer comprising β-nicotinamide mononucleotide, a pharmaceutically acceptable salt thereof or a solvate thereof, and a dietary supplement containing the aforementioned secretion enhancer, which can he ingested in order to increase the secretion of adiponectin. Also disclosed are methods of treating insulin resistance-related diseases such as of metabolic syndrome, diabetes, hyperlipidemia, fatty liver disease, hypertension, obesity, and arteriosclerosis.
Owner:ORIENTAL YEAST +1
Aloe Vera Extract, Method of Producing Aloe Vera Extract, and Hyperglycemia Improving Agent
InactiveUS20090004307A1Significant hyperglycemia improving effectReduce contentOrganic active ingredientsBiocideAcute hyperglycaemiaLifestyle disease
The present invention provides: an Aloe vera extract that can be safely ingested, can be used as a material of food for preventing lifestyle diseases, contains an extremely low level of an anthraquinone (anthraquinone-based compound), and can be added to foods; and a method of producing the Aloe vera extract. A supercritical fluid extraction method can produce an Aloe vera extract containing a mixture that consists of a cyclolanostane compound and a lophenol compound in an amount of 1.0% by mass or more and having the following properties (1) and / or (2):(1) the mass mixing ratio of the cyclolanostane compound and lophenol compound is as follows:cyclolanostane compound: lophenol compound=6.3:2.7 to 5.1:4.9; and / or(2) the content of an anthraquinone-based compound is 0.001% by mass or less.
Owner:MORINAGA MILK IND CO LTD
Fragmentor for bird ingestible gas turbine engine
InactiveUS7963094B1Low densitySafely ingestedBlade accessoriesEfficient propulsion technologiesLow densityFan blade
In an aircraft turbofan or turbojet engine including a fan blade assembly mounted thereon rotating about the central axis of the engine, there are provided aerodynamically profiled rotating cutting rings arranged concentrically to the engine axis upstream of the fan blade assembly on which a bird traveling toward the engine will fragment to extravasations and evisceration to produce bird debris of a sufficiently low density to be safely ingested by the engine.
Owner:CUPOLO FRANCIS J
Drug and Food or Drink for Improving Pancreatic Functions
ActiveUS20080255077A1Improved pancreatic functionImprove cell functionBiocideMetabolism disorderAlcoholMedicine
Compounds such as 4-methylcholest-7-en-3-ol, 4-methylergost-7-en-3-ol and 4-methylstigmast-7-en-3-ol which have an activity for improving pancreatic function are used as an active ingredient of a pancreas function improving drug and food or drink.
Owner:MORINAGA MILK IND CO LTD
Tofacitinib oral sustained release dosage forms
ActiveUS9937181B2Minimize biasReduced activityNervous disorderAntipyreticSustained release drugTofacitinib
Owner:PFIZER INC
Method of making cannabis oil hydrophilic using emulsifiers, related cannabinoid compositions, cannabinoid and caffeine emulsifications and cannabis infused sweeteners and elixirs
ActiveUS20190060227A1Highly metabolizableAct quicklyEdible oils/fats ingredientsOrganic active ingredientsCannabisCannabinoid
Owner:SRE WELLNESS INC
Composition for preventing or improving peripheral neuropathy
InactiveUS20170035721A1Safely ingestedImprove the quality of lifeOrganic active ingredientsNervous disorderN-3 fatty acidsSerine
Compositions which contain an amino acid containing serine and a lipid containing a n-3 fatty acid are useful for the prophylaxis or improvement of peripheral neuropathy.
Owner:AJINOMOTO CO INC
Drug and food or drink for improving hyperglycemia
ActiveUS20070196435A1Improving hyperglycemiaSafely ingestedOrganic active ingredientsBiocideAcute hyperglycaemiaMedicine
A compound having a cyclolanostane skeleton such as 9,19-cyclolanostan-3-ol and 24-methylene-9,19-cyclolanostan-3-ol is used as an active ingredient of a drug or food or drink for improving hyperglycemia.
Owner:MORINAGA MILK IND CO LTD
Highly bioavailable oral administration composition of cryptoxanthin
InactiveUS20090258111A1Safely ingestedImprove antioxidant capacityHydroxy compound active ingredientsTea extractionNatural productOral medication
A composition having improved bioavailability, of cryptoxanthin derived from a natural product, particularly that derived from Citrus unshiu Marc known to be rich in cryptoxanthin, and a method for economically and conveniently producing the same are provided. As a cryptoxanthin highly bioavailable oral administration composition, which is a composition comprising natural product-derived cryptoxanthin, wherein the amount of dietary fibers contained in said composition is 400 times by weight or less based on cryptoxanthin, this composition is a composition wherein the bioavailability of cryptoxanthin is improved 2 times or more in comparison with the case of directly ingesting a natural product containing said cryptoxanthin.
Owner:UNITIKA LTD
Agent for improving insulin resistance
ActiveUS8236769B2Improve insulin resistanceWeight increaseBiocideOrganic active ingredientsFamily liliaceaeOrganic solvent
Owner:MORINAGA MILK IND CO LTD
Agent for improving insulin resistance
ActiveUS20100035851A1Improve insulin resistanceWeight increaseBiocideOrganic active ingredientsFamily liliaceaeOrganic solvent
To inhibit production of adipocytokines, in particular, adipocytokines that elicit insulin resistance and to prevent onset of pathosis caused by the insulin resistance, or improve the pathosis, the present invention provides an agent or a food or drink which contains a compound having a cyclolanostane skeleton, or an organic solvent extract, a hot water extract of a plant of the family Liliaceae or Gramineae, or a fraction thereof which contains the compound as an active ingredient.
Owner:MORINAGA MILK IND CO LTD
Agent for inhibiting visceral fat accumulation
ActiveUS20090093450A1Effectively inhibiting accumulationSafely ingestedOrganic active ingredientsMetabolism disorderOrganic solventAbdominal cavity
To reduce amounts of fat accumulated in abdominal cavity and to prevent or ameliorate visceral fat type obesity, considered to be a main factor of metabolic syndrome, the present invention provides an agent or a food or drink which contains a compound having a lophenol skeleton, or an organic solvent extract or a hot water extract of a Liliaceae plant, or a fraction thereof containing the compound is used as an active ingredient.
Owner:MORINAGA MILK IND CO LTD
Agent for improving insulin resistance
ActiveUS20090312275A1Improve insulin resistanceWeight increaseBiocideSenses disorderFamily liliaceaeOrganic solvent
To inhibit production of adipocytokines, in particular, adipocytokines that elicit insulin resistance and to prevent onset of pathosis caused by the insulin resistance, or improve the pathosis, the present invention provides an agent or a food or drink which contains 3-O-β-D-glucopyranosyl-4-methylergost-7-en-3-ol, or an organic solvent extract, a hot water extract or a squeezed liquid of a plant of the family Liliaceae or a fraction thereof which contains the compound as an active ingredient.
Owner:MORINAGA MILK IND CO LTD
Fluid Supplement with Prenatal Vitamins
InactiveUS20130115201A1Combat symptom of nausea and vomitingImprove palatabilityBiocideSugar food ingredientsFlavorDietary supplement
A fluid supplement is provided that is specifically tailored to meet the health and nutritional needs of a pregnant woman and her developing fetus. The fluid supplement also combats the symptoms of nausea and vomiting that are commonly associated with pregnancy. The fluid supplement contains vitamins, minerals, dietary supplements, and flavor-enhancing ingredients in amounts that safely provide health and nutritional benefits to both the woman and her developing fetus. By using the fluid supplement, a pregnant woman is able to obtain the health and nutritional benefits in a single dose of a palatable fluid supplement instead of having to swallow multiple pills per day.
Owner:GLEESON MICHAEL PATRICK
Agent for inhibiting visceral fat accumulation
ActiveUS20100286104A1Reduce the amount requiredReduce weightOrganic active ingredientsMetabolism disorderAbdominal cavityOrganic solvent
Owner:MORINAGA MILK IND CO LTD
Glycoside having 4-methylergost-7-en-3-ol skeleton and hyperglycemia improving agent
ActiveUS20090075913A1Safely ingestedEasy to getBiocideOrganic active ingredientsAcute hyperglycaemiaGlycoside
Owner:MORINAGA MILK IND CO LTD
Drug for improving hyperglycemia
ActiveUS20100240632A1Safely ingestedImproving hyperglycemiaOrganic active ingredientsSenses disorderAcute hyperglycaemiaAlcohol
A compound having a hyperglycemia improving effect and a hemoglobin A1c lowering action such as 4-methylcholest-7-en-3-ol, 4-methylergost-7-en-3-ol and 4-methylstigmast-7-en-3-ol is used as an active ingredient of a drug or food or drink for improving hyperglycemia.
Owner:MORINAGA MILK IND CO LTD
Tamper-evident containers
Various tamper-evident and / or tamper-resistant containers are disclosed. In some embodiments, the container comprises a base and a lid. The base can receive a food product. The lid can be engaged with the base to form a closed chamber in the container. In some embodiments, the lid is received in a peripheral channel in the base and / or recessed below an upper lip of the base to inhibit grasping of a peripheral edge of the lid. The lid can have a tab and a recess. The tab can be positioned in the recess. An indicator can overlay the tab in the recess. To open the container, the tab is drawn upward which pulls the lid out of engagement with the base. Removing the tab from the recess tears or otherwise mars the appearance of the indicator.
Owner:PINNPACK PACKAGING LLC
Drug And Food Or Drink For Improving Pancreatic Functions
ActiveUS20080125379A1Function increaseImprove cell functionOrganic active ingredientsBiocideAlcoholFamily liliaceae
3-O-β-D-Glucopyranosyl-4-methyl-ergost-7-en-3-ol or a composition containing 0.001 to 10% by dry mass of the aforementioned compound, which is an extract of a plant of the family Liliaceae or a fraction thereof containing the compound, is used as an active ingredient of a drug for improving pancreatic functions.
Owner:MORINAGA MILK IND CO LTD
Drug and food or drink for improving pancreatic functions
ActiveUS7531520B2Function increaseEasy to getBiocideOrganic active ingredientsPANCREATIC FUNCTIONSFamily liliaceae
Owner:MORINAGA MILK IND CO LTD
Adiponectin secretion enhancer
ActiveUS10695360B2Increase secretionSafely ingestedCosmetic preparationsDispersion deliveryFatty liverDietary supplement
Owner:ORIENTAL YEAST +1
Drug and food or drink for improving hyperglycemia
ActiveUS7674784B2Safely ingestedImproving hyperglycemiaOrganic active ingredientsBiocideAcute hyperglycaemiaAlcohol
Owner:MORINAGA MILK IND CO LTD
Compositions and methods for oral administration of cannabinoids and terpenoids
InactiveUS20210077389A1Precise and reliable dosageAct quicklyOrganic active ingredientsPowder deliveryOral medicationDelivery vehicle
The present invention relates to oral administration of water soluble cannabinoid and terpenoid concentrates on a flavored fibrous carrier. The compositions described herein provide an alternative to smoked cannabis that also avoid the slow action and unpredictable dosing of edible cannabis preparations. Water soluble concentrates of cannabinoids and terpenoids may be produced by derivatization reactions which are known in the art. Such water soluble concentrates enjoy significantly increased absorption by mucosal membranes of the mouth and may therefore be experienced by the consumer more quickly. Water soluble cannabinoid and terpenoid concentrates may be used in combination with each other and in combination with non-derivatized molecules which provides the user with fast and slow acting components in a single delivery vehicle.
Owner:TRINIDAD CONSULTING LLC
Agent for inhibiting visceral fat accumulation
ActiveUS20090069254A1Reduce the amount presentInhibition is effectiveBiocideOrganic active ingredientsD-GlucopyranoseAbdominal cavity
To reduce amounts of fat accumulated in abdominal cavity and to prevent or ameliorate visceral fat type obesity considered to be a main factor of metabolic syndrome, there is provided an agent or a food or drink, including as an active ingredient 3-O-β-D-glucopyranosyl-4-methylergost-7-en-3-ol, an organic solvent extract, a hot water extract, a squeezed liquid of a Liliaceae plant or a fraction thereof which contains the compound.
Owner:MORINAGA MILK IND CO LTD
Skin pigmentation inhibitor
ActiveUS20200016183A1Safely ingestedInhibiting skin pigmentationCosmetic preparationsOrganic active ingredientsPhysiologyNicotinamide mononucleotide
An object of the present invention is to provide a material which can be safely ingested and which inhibits skin pigmentation. Therefore, the invention is a skin pigmentation inhibitor, containing a β-nicotinamide mononucleotide or a pharmaceutically acceptable salt thereof; and a solvate thereof as an active ingredient; a health supplement which contains the skin pigmentation inhibitor and is ingested to inhibit skin pigmentation; and a method for inhibiting skin pigmentation, including ingesting the skin pigmentation inhibitor.
Owner:ORIENTAL YEAST
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com